CorMedix Inc.

CRMD | NASDAQ

Price Alert Chart Builder DCF Calculator

$7.77

+$0.05 (+0.65%)

At close: Sep 21, 2026, 4:00 PM ET

$7.77

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.65%

(1D)

Rating

Updated: Aug 31, 2026

Fundamentals Excellent

Market Sentiment Neutral

Moat Narrow

Full Analysis

Key Statistics

Market Data

Market Cap $609.57M

1D Range

7.69 7.82

52W Range

6.13 13.02

Valuation (TTM)

PE 3.65

PB 1.32

EV/EBITDA 2.00

Valuation (NTM)

Forward PE 125.07

Forward PEG -0.04

Price Target $14

Cash Flow

FCF Yield 41.3%

SBC Adj. FCF Yield 40.0%

SBC Impact -3.0%

Margins

Gross Margin 82.8%

Operating Margin 47.0%

FCF Margin 54.5%

Growth (CAGR)

Revenue 3Y | 5Y 2230.5% | 351.9%

Dil EPS 3Y | 5Y 235.4% | 1160.9%

FCF 3Y | 5Y 196.8% | 176.2%

Returns

ROA 20.7%

ROE 44.6%

ROIC 27.9%

Financial Health

Net Cash

$111.54M

Current Ratio 2.56

Interest Coverage 78.49

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

CorMedix Inc. is a biopharmaceutical company engaged in the development and commercialization of medical treatments for the prevention and care of infectious and inflammatory conditions, serving marke...

Sector Healthcare

Industry Biotechnology

Employees 191

IPO Date May 12, 2010

Website www.cormedix.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 11, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$14

Upside

+80.18%

Buy (6)

Hold (0)

Sell (0)

Analyst Details ➞